| Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma E Cantor, K Wierzbicki, RS Tarapore, K Ravi, C Thomas, R Cartaxo, ... Neuro-oncology 24 (8), 1366-1374, 2022 | 51 | 2022 |
| Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways S Venneti, AR Kawakibi, S Ji, SM Waszak, SR Sweha, M Mota, M Pun, ... Cancer discovery 13 (11), 2370-2393, 2023 | 34 | 2023 |
| Cell-free tumor DNA (cf-tDNA) liquid biopsy: Current methods and use in brain tumor immunotherapy J Wadden, K Ravi, V John, CM Babila, C Koschmann Frontiers in Immunology 13, 882452, 2022 | 13 | 2022 |
| Liquid biopsy in pediatric brain tumors A Tripathy, V John, J Wadden, S Kong, S Sharba, C Koschmann Frontiers in Genetics 13, 1114762, 2023 | 6 | 2023 |
| Ultra-rapid somatic variant detection via real-time targeted amplicon sequencing J Wadden, BS Newell, J Bugbee, V John, AK Bruzek, RP Dickson, ... Communications Biology 5 (1), 708, 2022 | 6 | 2022 |
| CONCATEMERIC CONSENSUS ERROR CORRECTED SEQUENCING (CCEC-SEQ) APPROACH FOR PLASMA CELL-FREE TUMOR DNA-BASED TREATMENT RESPONSE MONITORING IN PATIENTS WITH BRAIN TUMORS J Wadden, V John, R Aittaleb, C Koschmann NEURO-ONCOLOGY 25, 2023 | | 2023 |
| BIOM-58. ZERO-WASTE MOLECULAR DIAGNOSTICS FROM BIOPSY NEEDLE WASHES J Wadden, V John, M Niculcea, S Kong, R Aittaleb, R Cartaxo, K Verbal, ... Neuro-Oncology 25 (Supplement_5), v17-v18, 2023 | | 2023 |
| TMET-02. CLINICAL EFFICACY OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMAS IS DRIVEN BY DISRUPTION OF INTEGRATED METABOLIC AND EPIGENETIC PATHWAYS S Venneti, AR Kawakibi, S Ji, S Waszak, S Sweha, M Mota, M Pun, ... Neuro-Oncology 25 (Supplement_5), v272-v272, 2023 | | 2023 |
| Zero-waste molecular diagnostics from biopsy needle wash water J Wadden, V John, S Kong, K Verbal, AK Bruzek, W Al-Holou, JA Heth, ... Cancer Research 83 (7_Supplement), 2115-2115, 2023 | | 2023 |
